Deutsche Bank’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.9K Hold
12,397
﹤0.01% 3357
2025
Q4
$152K Buy
12,397
+733
+6% +$12K ﹤0.01% 3143
2025
Q3
$239K Buy
11,664
+1,950
+20% +$30.9K ﹤0.01% 2969
2025
Q2
$131K Hold
9,714
﹤0.01% 3151
2025
Q1
$84.1K Hold
9,714
﹤0.01% 3247
2024
Q4
$47.2K Hold
9,714
﹤0.01% 3424
2024
Q3
$75K Buy
9,714
+3,150
+48% +$28K ﹤0.01% 3279
2024
Q2
$65.6K Sell
6,564
-1,392
-17% -$15.3K ﹤0.01% 3263
2024
Q1
$96.7K Sell
7,956
-315
-4% -$4.57K ﹤0.01% 3186
2023
Q4
$118K Buy
8,271
+993
+14% +$9.53K ﹤0.01% 3143
2023
Q3
$56.6K Hold
7,278
﹤0.01% 3376
2023
Q2
$104K Sell
7,278
-3,309
-31% -$47.1K ﹤0.01% 3258
2023
Q1
$155K Buy
10,587
+2,885
+37% +$48.3K ﹤0.01% 3126
2022
Q4
$129K Buy
7,702
+162
+2% +$2.8K ﹤0.01% 3205
2022
Q3
$111K Sell
7,540
-2,787
-27% -$55.1K ﹤0.01% 3266
2022
Q2
$283K Sell
10,327
-525
-5% -$15.6K ﹤0.01% 2958
2022
Q1
$409K Sell
10,852
-1,285
-11% -$56.9K ﹤0.01% 2870
2021
Q4
$754K Buy
12,137
+490
+4% +$37.1K ﹤0.01% 2595
2021
Q3
$996K Sell
11,647
-77
-0.7% -$4.83K ﹤0.01% 2612
2021
Q2
$726K Buy
11,724
+972
+9% +$49.5K ﹤0.01% 2985
2021
Q1
$524K Sell
10,752
-94
-0.9% -$4.54K ﹤0.01% 3068
2020
Q4
$338K Buy
10,846
+3,044
+39% +$74.6K ﹤0.01% 3161
2020
Q3
$163K Buy
7,802
+702
+10% +$12.1K ﹤0.01% 3322
2020
Q2
$92K Buy
7,100
+2,308
+48% +$25.1K ﹤0.01% 3472
2020
Q1
$43K Sell
4,792
-277
-5% -$2.63K ﹤0.01% 3620
2019
Q4
$51K Buy
5,069
+888
+21% +$10.1K ﹤0.01% 3960
2019
Q3
$58K Sell
4,181
-11,438
-73% -$177K ﹤0.01% 3856
2019
Q2
$252K Buy
15,619
+9,458
+154% +$128K ﹤0.01% 3692
2019
Q1
$78K Buy
+6,161
New +$80.1K ﹤0.01% 4390
2018
Q4
Sell
-550
Closed -$10K 5338
2018
Q3
$10K Buy
+550
New +$6.93K ﹤0.01% 5080

Other funds holding OPRX

Deutsche Bank's OPRX Position: Q1 2026 in Review

Deutsche Bank held its OptimizeRx (OPRX) position steady in Q1 2026 at 12,397 shares worth $77.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3357.

Deutsche Bank first reported a position in OPRX in Q3 2018 and has held it in 30 quarters since. The position peaked at $996K in Q3 2021. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Deutsche Bank held 12,397 shares of OptimizeRx worth $77.9K as of Q1 2026.
  • Deutsche Bank left its OptimizeRx share count unchanged in Q1 2026.
  • OptimizeRx made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3357 holding.
  • Deutsche Bank first reported a position in OptimizeRx in Q3 2018 and has held it in 30 quarters since.
  • Deutsche Bank's OptimizeRx position peaked at $996K in Q3 2021.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.